Compare CVEO & XOMA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | CVEO | XOMA |
|---|---|---|
| Founded | 1977 | 1981 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Hotels/Resorts | Biotechnology: Pharmaceutical Preparations |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 291.6M | 308.6M |
| IPO Year | 2013 | N/A |
| Metric | CVEO | XOMA |
|---|---|---|
| Price | $28.85 | $27.17 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 1 | 5 |
| Target Price | $37.00 | ★ $60.60 |
| AVG Volume (30 Days) | 79.3K | ★ 134.0K |
| Earning Date | 06-10-2026 | 01-01-0001 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | N/A | ★ N/A |
| Revenue | N/A | N/A |
| Revenue This Year | $8.12 | $76.93 |
| Revenue Next Year | $3.11 | $29.28 |
| P/E Ratio | ★ N/A | $29.64 |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $18.01 | $18.40 |
| 52 Week High | $29.68 | $39.92 |
| Indicator | CVEO | XOMA |
|---|---|---|
| Relative Strength Index (RSI) | 62.92 | 56.70 |
| Support Level | $22.05 | $23.92 |
| Resistance Level | $29.33 | $27.68 |
| Average True Range (ATR) | 1.04 | 1.45 |
| MACD | -0.05 | 0.22 |
| Stochastic Oscillator | 81.76 | 90.76 |
Civeo Corp provides hospitality services to the natural resources industry in Canada, Australia and the United States. The company provides a full suite of services for guests, including lodging, catering and food service, housekeeping and maintenance at accommodation facilities that the company or its customers own. The company provides services that support the day-to-day operations of these facilities, such as laundry, facility management and maintenance, water and wastewater treatments, power generation, communication systems, security and logistics. The company operates in active oil, metallurgical coal, liquefied natural gas and iron ore-producing regions. The company operates in three reportable business segments Canada, Australia and the United States.
XOMA Royalty Corp is a biotechnology royalty aggregator playing a role in helping biotech companies achieve their goal of improving human health. XOMA acquires the potential future economics associated with pre-commercial therapeutic candidates that have been licensed to pharmaceuticals or biotechnology companies. XOMA acquires future economic rights, the seller receives non-dilutive, non-recourse funding that can use to advance their internal drug candidate(s) or for general corporate purposes. Geographically, the company operates in Switzerland, United States, Asia Pacific, Europe and Others.